Serum plant sterols, cholestanol, and cholesterol precursors associate with histological liver injury in pediatric onset intestinal failure

American Journal of Clinical Nutrition

Volumn 100, Issue 4, 2014, Pages 1085-1094

  Mutanen, Annika ^a   Nissinen, Markku J ^c   Lohi, Jouko ^b   Heikkilä, Päivi ^b   Gylling, Helena ^c   Pakarinen, Mikko P ^a  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN GLUCURONIDE; CAMPESTEROL; CHOLESTANOL; CHOLESTEROL; DESMOSTEROL; LATHOSTEROL; PHYTOSTEROL; SITOSTEROL; STIGMASTEROL; BILE ACID;

ARTICLE; BILE ACID BLOOD LEVEL; CHILD; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; INTESTINAL FAILURE; LIVER BIOPSY; LIVER FUNCTION; LIVER HISTOLOGY; LIVER INJURY; MALE; PARENTERAL NUTRITION; PROSPECTIVE STUDY; ADOLESCENT; BLOOD; BODY MASS; BODY WEIGHT; ENTEROPATHY; INTESTINE; LIVER DISEASE; METABOLISM; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; BILE ACIDS AND SALTS; BODY MASS INDEX; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CHOLESTANOL; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTESTINAL DISEASES; INTESTINES; LIVER DISEASES; MALE; PARENTERAL NUTRITION; PHYTOSTEROLS; PROSPECTIVE STUDIES; STIGMASTEROL;

EID: 84907262441     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.088781     Document Type: Article

References (45)

1. Goulet O, Ruemelle F, Lacaille F, Colomb V. Irreversible intestinal failure. J Pediatr Gastroenterol Nutr 2004;38:250-69.
2. Carter BA, Karpen SJ. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Semin Liver Dis 2007;27:251-8.
3. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006;130:S70-7.
4. Mutanen A, Lohi J, Heikkilä P, Koivusalo AI, Rintala RJ, Pakarinen MP. Abnormal liver fibrosis after weaning off parenteral nutrition in pediatric onset intestinal failure. Hepatology 2013;58:729-38.
5. Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, Kuzma- O'Reilly B, Teitelbaum DH. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg 2005;242:403-9.
6. Kelly DA. Preventing parenteral nutrition liver disease. Early Hum Dev 2010;86:683-7.
7. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993;105:1806-13.
8. Hallikainen M, Huikko L, Kontra K, Nissinen M, Piironen V, Miettinen T, Gylling H. Effect of parenteral plant sterols on liver enzymes and cholesterol metabolism in a patient with short bowel syndrome. Nutr Clin Pract 2008;23:429-35.
9. Llop JM, Virgili N, Moreno-Villares JM, Garcia-Peris P, Serrano T, Forga M, Solanich J, Pita AM. Phytosterolemia in parenteral nutrition patients: implications for liver disease development. Nutrition 2008;24:1145-52.
10. Kurvinen A, Nissinen MJ, Andersson S, Korhonen P, Ruuska T, Taimisto M, Kalliomäki M, Lehtonen L, Sankilampi U, Arikoski P, et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastroenterol Nutr 2012;54:803-11.
11. Kurvinen A, Nissinen MJ, Gylling H, Miettinen TA, Lampela H, Koivusalo AI, Rintala RJ, Pakarinen MP. Effects of long-term parenteral nutrition on serum lipids, plant sterols, cholesterol metabolism, and liver histology in pediatric intestinal failure. J Pediatr Gastroenterol Nutr 2011;53:440-6.
12. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999;3:543-53.
13. Carter BA, Taylor OA, Prendergast SR, Zimmerman TL, Von Furstenberg R, Moore DD, Karpen SJ. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007;62: 301-6.
14. El Kasmi KC, Anderson AL, Devereaux MW, Vue PM, Zhang W, Setchell KD, Karpen SJ, Sokol RJ. Phytosterols promote liver injury and kuppfer cell activation in parenteral nutrition-associated liver disease. Sci Transl Med 2013;5:206ra137.
15. Mutanen A, Heikkilä P, Lohi J, Raivio T, Jalanko H, Pakarinen MP. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure. J Hepatol 2014;60:183-90.
16. Pakarinen MP, Kurvinen A, Gylling H, Miettinen TA, Pesonen M, Kallio M, Koivusalo AI, Nissinen MJ. Cholesterol metabolism in pediatric short bowel syndrome after weaning off parenteral nutrition. Dig Liver Dis 2010;42:554-9.
17. Soden JS. Clinical assessment of the child with intestinal failure. Semin Pediatr Surg 2010;19:10-9.
18. Freudenberg F, Gothe F, Beigel F, Rust C, Koletzko S. Serum 7-alphahydroxy- 4-cholesten23-one as a marker for bile acid loss in children. J Pediatr 2013;163:1367-71.
19. Hazard SE, Patel SB. Sterolins ABCG5 and ABCG8: regulators of whole body dietary sterols. Pflugers Arch 2007;453:745-52.
20. Herrema H, Meissner M, vanDijk TH, Brufau G, Boverhof R, Oosterveer MH, Reijngoud DJ, Müller M, Stellaard F, Groen AK, et al. Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor a-controlled metabolic pathways in mice. Hepatology 2010;51:806-16.
21. Matsubara T, Li F, Gonzalez FJ. FXR signaling in the enterohepatic system. Mol Cell Endocrinol 2013;368:17-29.
22. Fuchs C, Claudel T, Trauner M. Bile acid-mediated control of liver triglycerides. Semin Liver Dis 2013;33:330-42.
23. Beaven SW, Wroblewski K, Wang J, Hong C, Bensinger S, Tsukamoto H, Tontonoz P. Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease. Gastroenterology 2011;140:1052-62.
24. Nikkilä K, Höckerstedt K, Miettinen TA. High cholestanol and low campesterol-to-sitosterol ratio in serum of patients with primary biliary cirrhosis before liver transplantation. Hepatology 1991;13:663-9.
25. Gylling H, Vuoristo M, Färkkilä M, Miettinen TA. The metabolism of cholestanol in primary biliary cirrhosis. J Hepatol 1996;24:444-51.
26. Nikkilä K, Nissinen MJ, Gylling H, Isoniemi H, Miettinen TA. Serum sterols in patients with primary biliary cirrhosis and acute liver failure before and after liver transplantation. J Hepatol 2008;49:936-45.
27. Pakarinen MP, Lampela H, Gylling H, Miettinen TA, Koivusalo AI, Nissinen MJ. Surrogate markers of cholesterol metabolism in children with native liver after successful portoenterostomy for biliary atresia. J Pediatr Surg 2010;45:1659-64.
28. Fitzgibbons SC, Jones BA, Hull MA, Zurakowski D, Duro D, Duggan C, Boctor D, Sigalet DL, Jaksic T. Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. J Pediatr Surg 2010;45: 95-9.
29. Beath SV, Davies P, Papadopoulou A, Khan AR, Buick RG, Corkery JJ, Gornall P, Booth IW. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 1996;31:604-6.
30. Pakarinen MP, Kurvinen A, Koivusalo AI, Iber T, Rintala RJ. Longterm controlled outcomes after autologous intestinal reconstruction surgery in treatment of severe short bowel syndrome. J Pediatr Surg 2013;48:339-44.
31. Pakarinen MP, Kurvinen A, Koivusalo AI, Ruuska T, Mäkisalo H, Jalanko H, Rintala RJ. Surgical treatment and outcomes of severe pediatric intestinal motility disorders requiring parenteral nutrition. J Pediatr Surg 2013;48:333-8.
32. Struijs MC, Diamond IR, de Silva N, Wales PW. Establishing norms for intestinal length in children. J Pediatr Surg 2009;44:933-8.
33. Saari A, Sankilampi U, Hannila ML, Kiviniemi V, Kesseli K, Dunkel L. New Finnish growth references for children and adolescents aged 0 to 20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med 2011;43:235-48.
34. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-26.
35. Miettinen TA. Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 1988;29:43-51.
36. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93.
37. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998;339:1217-27.
38. Tazuke Y, Teitelbaum DH. Alterations of canalicular transporters in a mouse model of total parenteral nutrition. J Pediatr Gastroenterol Nutr 2009;48:193-202.
39. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted distribution of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000;102:731-44.
40. Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, MacKenzie KI, Mansfield TA, Kliewer SA, Goodwin B, Jones SA. Hepatoprotection by the farnesoid x receptor agonist QW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 2003;112:1678-87.
41. Vlaardingerbroek H, Ng K, Stoll B, Benight N, Chacko S, Kluijtmans LA, Kulik W, Squires EJ, Olutoye O, Schady D, et al. New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs. J Lipid Res 2014;55:466-77.
42. McMahan RH, Wang XX, Cheng LL, Krisko T, Smith M, El Kasmi K, Pruzanski M, Adorini L, Golden-Mason L, Levi M, et al. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease. J Biol Chem 2013;288:11761-70.
43. Mutanen A, Mäkitie O, Pakarinen MP. Risk of metabolic bone disease is increased both during and after weaning off parenteral nutrition in pediatric intestinal failure. Horm Res Paediatr 2013;79:227-35.
44. Cyphert HA, Ge X, Kohan AB, Salati LM, Zhang Y, Hillgartner FB. Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21. J Biol Chem 2012;287:25123-38.
45. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism 1989;38:136-40.